Marketing Exclusivity for Over-the-Counter Switched Products

Posted 19 December 2017 By Deborah Livornese

placeholder+image This article discusses the regulatory process for changing a drug's status from "prescription only" to Over-the-Counter (OTC) and discusses issues related to gaining exclusivity for OTC switched products under FDA regulations and guidance and Congressional legislation.

Share this article:

Categories: Prescription drugs, Over the counter drugs, Features, FDA

Tags: OTC Switch, Marketing Exclusivity

Regulatory Exchange: Latest Updates From the Community